Multi-Cancer Early Detection provides a private blood-based cancer screening service in Western Canada, designed to identify signals associated with up to 59 types of cancer before symptoms appear. The test analyzes tumour-related DNA fragments in a blood sample using genomic technology, with samples processed at a specialized laboratory in Toronto. The company describes the test as research use only in Canada and says it does not replace routine screening, such as mammograms, cervical screening, or colon cancer tests.

Customers begin with a consultation to discuss eligibility and next steps, followed by a blood draw at a partner clinic or through a mobile service available across major Western Canadian cities. Results typically take up to three weeks. If a result is positive, the service says it arranges a complimentary private CT scan or MRI and, when required, an urgent oncology referral. Physician guidance and ongoing support are also offered throughout the process.